- Motley Fool•2 hours ago
The healthcare giant Johnson & Johnson lost favor with three of the world's best investors last quarter. Should retail investors be concerned?
- Insider Monkey•20 hours ago
Times are tough for healthcare stocks as investors keep a distance from the sector following drug-pricing control concerns and political clamor. However, analysts think that as the overpricing factor trims, healthcare stocks become feasible to accumulate as long positions. For this article, we have used data from the latest round of 13F filings and have […]
- TheStreet.com•23 hours ago
Johnson & Johnson, the most consistent dividend stock in the world with 54 consecutive increases, has also had 32 straight adjusted earnings-per-share increases.
Johnson & Johnson (JNJ)
NYSE - NYSE Real Time Price. Currency in USD
|Day's Range||119.06 - 120.13|
|52wk Range||89.90 - 126.07|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||22.35|
|Avg Vol (3m)||6,854,220|
|Dividend & Yield||3.20 (2.69%)|